Ampio Pharmaceuticals News - AMPE

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Ampio Pharmaceuticals Inc AMPE AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.03 -5.66% 0.50 0.431 0.62 0.6194 0.53 19:23:08
more quote information »

Recent News

Date Time Source Heading
4/02/202009:00PRNUSAmpio Pharmaceutical's Application to the FDA for a Clinical..
3/24/202008:33EDGARCurrent Report Filing (8-k)
3/24/202007:00PRNUSAmpio Suspends Patient Enrollment in its Phase 3 Study of..
3/24/202006:30PRNUSAmpio is Preparing an Expanded Access FDA protocol to Study..
2/21/202007:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/21/202006:30PRNUSAmpio Provides Corporate Update
2/21/202006:15EDGARAnnual Report (10-k)
2/20/202016:18EDGARCurrent Report Filing (8-k)
12/04/201908:30PRNUSAmpio Provides Update on AP-013 Phase III Clinical Trial and..
11/07/201916:34EDGARQuarterly Report (10-q)
10/31/201916:31EDGARProxy Statement (definitive) (def 14a)
10/29/201906:03EDGARCurrent Report Filing (8-k)
10/21/201916:36EDGARStatement of Changes in Beneficial Ownership (4)
10/16/201916:03EDGARProxy Statement - Notice of Shareholders Meeting..
10/10/201916:02EDGARCurrent Report Filing (8-k)
10/10/201908:30PRNUSAmpio Provides Update on Continued Progress of AP-013 Phase..
9/20/201916:02EDGARCurrent Report Filing (8-k)
9/18/201908:30PRNUSAmpio Retains Legal Counsel for Transaction Advisory..
9/17/201908:30PRNUSAmpio Pharmaceuticals Updates Progress of SPA Clinical Trial
9/11/201917:47EDGARStatement of Changes in Beneficial Ownership (4)
9/11/201917:32EDGARStatement of Changes in Beneficial Ownership (4)
9/11/201917:13EDGARStatement of Changes in Beneficial Ownership (4)
8/23/201916:03EDGARCurrent Report Filing (8-k)
8/22/201915:05EDGARStatement of Changes in Beneficial Ownership (4)
8/22/201908:30PRNUSAmpio Pharmaceuticals Retains Financial Advisor and Appoints..
8/09/201916:04EDGARQuarterly Report (10-q)
8/01/201917:23EDGARStatement of Changes in Beneficial Ownership (4)
8/01/201917:01EDGARInitial Statement of Beneficial Ownership (3)
7/25/201908:30PRNUSAmpio Pharmaceuticals Updates Progress of SPA Clinical Trial
7/11/201916:02EDGARCurrent Report Filing (8-k)
7/11/201908:30PRNUSAmpio Appoints Moss Adams LLP as the Company's New..
7/10/201916:03EDGARCurrent Report Filing (8-k)
7/10/201908:30PRNUSAmpio Appoints Dan Stokely as the Company's new Chief..
6/20/201915:47EDGARStatement of Ownership (sc 13g)
6/19/201916:02EDGARCurrent Report Filing (8-k)
6/19/201916:01PRNUSAmpio Pharmaceuticals Announces Closing of $12 Million..
6/17/201910:47EDGARStatement of Ownership (sc 13g)
6/17/201909:24EDGARCurrent Report Filing (8-k)
6/17/201908:22EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/17/201908:16PRNUSAmpio Pharmaceuticals Announces Pricing of Public Offering
6/17/201906:06EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/17/201906:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/14/201916:03EDGARCurrent Report Filing (8-k)
6/14/201916:01PRNUSAmpio Pharmaceuticals, Inc. Announces Proposed Public..
6/14/201907:31EDGARCurrent Report Filing (8-k)
6/14/201907:30PRNUSAmpio Regulatory and Clinical Update
6/13/201916:32EDGARCurrent Report Filing (8-k)
5/22/201909:31EDGARCurrent Report Filing (8-k)
5/22/201908:30PRNUSAmpio Clinical, Regulatory and Corporate Update
5/10/201917:26EDGARQuarterly Report (10-q)
See more news about this stock »


Your Recent History
AMEX
AMPE
Ampio Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.